Matches in Wikidata for { <http://www.wikidata.org/entity/Q63340990> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- Q63340990 description "clinical trial" @default.
- Q63340990 description "ensayu clínicu" @default.
- Q63340990 description "klinisch onderzoek" @default.
- Q63340990 description "клінічне випробування" @default.
- Q63340990 name "A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis" @default.
- Q63340990 type Item @default.
- Q63340990 label "A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis" @default.
- Q63340990 prefLabel "A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis" @default.
- Q63340990 P1050 Q63340990-DAEBF175-CC7F-4E89-9657-35E1180F4F21 @default.
- Q63340990 P1132 Q63340990-18CAD5BC-47DE-4C06-915E-E3FB61269796 @default.
- Q63340990 P1476 Q63340990-2E0867F6-33CE-4834-BDC0-CA22A8EB4688 @default.
- Q63340990 P17 Q63340990-020E50A0-72BD-4368-B25C-7F2D4E16AE07 @default.
- Q63340990 P17 Q63340990-04E2E127-CE30-4939-A122-3E0839E6133F @default.
- Q63340990 P17 Q63340990-06827CE6-F348-4977-BEB2-44C6D85A7818 @default.
- Q63340990 P17 Q63340990-0AC914BE-2D23-46F2-8FEC-3F2272FD8E8F @default.
- Q63340990 P17 Q63340990-245AA526-0D64-4AF6-B6AD-4F6EA22DFBF9 @default.
- Q63340990 P17 Q63340990-45D31D66-634D-4AAE-AEAB-4CB6F93C577D @default.
- Q63340990 P17 Q63340990-4ABAC144-2657-4A9A-B963-095C7277DDBE @default.
- Q63340990 P17 Q63340990-6086C4F6-71B4-421F-A052-80AFF7C317FC @default.
- Q63340990 P17 Q63340990-63ABD9DF-F947-4991-92FA-BC7870F5E338 @default.
- Q63340990 P17 Q63340990-6F097474-074F-4BA0-8509-EED4398E0009 @default.
- Q63340990 P17 Q63340990-74ACFBBD-CE53-4E26-9A08-7B53006BD3CD @default.
- Q63340990 P17 Q63340990-B6FC0C20-28FC-483A-A30C-F929886A7C06 @default.
- Q63340990 P17 Q63340990-C272324F-F169-4B2F-8BF6-893B774E0098 @default.
- Q63340990 P17 Q63340990-CBC62A57-9211-46DD-BCFF-A2BF11C26C7E @default.
- Q63340990 P17 Q63340990-D4B9CA38-825B-4A9D-8B2D-798CAADAB97E @default.
- Q63340990 P17 Q63340990-D55CD812-32FD-41F8-A5A6-1C8B4C556A72 @default.
- Q63340990 P17 Q63340990-D8190FD8-39CE-4718-9862-18EB59EFDB43 @default.
- Q63340990 P17 Q63340990-DCF4EB17-4724-4F79-8A81-32AA807AA896 @default.
- Q63340990 P17 Q63340990-F2465DAD-F36F-44C4-9E70-7AB48E8D7BFB @default.
- Q63340990 P17 Q63340990-F58843F7-93D3-4D4C-A812-E6CA4102A1BC @default.
- Q63340990 P17 Q63340990-F9BF94FC-EDB5-44E3-9954-E8068B564309 @default.
- Q63340990 P2899 Q63340990-1B380B1F-46B3-43B8-80C7-391C01EA1FF6 @default.
- Q63340990 P3098 Q63340990-D9425DE5-7C8C-4E4A-9CE7-831883B2A6C3 @default.
- Q63340990 P31 Q63340990-B1BB49A7-099F-4F46-BDCF-0F82F4F60F1D @default.
- Q63340990 P580 Q63340990-A7DCA79C-07D8-4411-9706-83F00F0F9824 @default.
- Q63340990 P582 Q63340990-7E8893E3-FA3F-422E-AB1C-0C6DDD0EC05C @default.
- Q63340990 P6099 Q63340990-8EBB6AD6-5827-40BB-BA90-2CCFC1CC3D4D @default.
- Q63340990 P8363 Q63340990-30A10637-173D-4F5D-AA27-3483B3AFC18A @default.
- Q63340990 P859 Q63340990-779320FD-D2FD-4565-A549-739C8CC12A0D @default.
- Q63340990 P1050 Q170990 @default.
- Q63340990 P1132 "+656" @default.
- Q63340990 P1476 "A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis" @default.
- Q63340990 P17 Q155 @default.
- Q63340990 P17 Q16 @default.
- Q63340990 P17 Q219 @default.
- Q63340990 P17 Q258 @default.
- Q63340990 P17 Q28 @default.
- Q63340990 P17 Q29 @default.
- Q63340990 P17 Q30 @default.
- Q63340990 P17 Q36 @default.
- Q63340990 P17 Q39 @default.
- Q63340990 P17 Q408 @default.
- Q63340990 P17 Q41 @default.
- Q63340990 P17 Q414 @default.
- Q63340990 P17 Q664 @default.
- Q63340990 P17 Q739 @default.
- Q63340990 P17 Q774 @default.
- Q63340990 P17 Q801 @default.
- Q63340990 P17 Q804 @default.
- Q63340990 P17 Q833 @default.
- Q63340990 P17 Q869 @default.
- Q63340990 P17 Q928 @default.
- Q63340990 P17 Q96 @default.
- Q63340990 P2899 "+18" @default.
- Q63340990 P3098 "NCT01232569" @default.
- Q63340990 P31 Q30612 @default.
- Q63340990 P580 "2011-03-01T00:00:00Z" @default.
- Q63340990 P582 "2012-05-01T00:00:00Z" @default.
- Q63340990 P6099 Q42824827 @default.
- Q63340990 P8363 Q78089383 @default.
- Q63340990 P859 Q212646 @default.